1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Aminoquinoline-based Re(I) tricarbonyl complexes : Insights into their antiproliferative activity and mechanisms of action
(
- Contribution to journal › Article
-
Mark
Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics
(
- Contribution to journal › Article
- 2023
-
Mark
Combining pharmacophore models derived from DNA-encoded chemical libraries with structure-based exploration to predict Tankyrase 1 inhibitors
(
- Contribution to journal › Article
- 2022
-
Mark
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3
(
- Contribution to journal › Article
- 2021
-
Mark
Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity
(
- Contribution to journal › Article
-
Mark
Benzimidazole–galactosides bind selectively to the Galectin-8 N-Terminal domain : Structure-based design and optimisation
(
- Contribution to journal › Article
- 2019
-
Mark
Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors : Synthesis, biological evaluation and X-ray structural studies
(
- Contribution to journal › Article
- 2018
-
Mark
Biological activity of doubly modified salinomycin analogs – Evaluation in vitro and ex vivo
(
- Contribution to journal › Article
-
Mark
Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity
(
- Contribution to journal › Article
- 2017
-
Mark
Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds
(
- Contribution to journal › Article